Significant Nationwide Variability in the Costs and Hospital Mortality Rates of Autologous Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample Database

Biology of Blood and Marrow Transplantation - Tập 25 - Trang 41-46 - 2019
Yuzhou Liu1, Hedong Han2, Gunjan Shah3,4, Sergio Giralt3,4, C. Ola Landgren3,4, Jia He2, Alexander M. Lesokhin3,4
1Department of Medicine, Icahn School of Medicine at Mount Sinai St. Luke's and Mount Sinai West, New York, New York
2Department of Health Statistics, Second Military Medical University, Shanghai, China
3Department of Medicine, Weill Cornell Medical College, New York, New York
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

Tài liệu tham khảo

Siegel, 2017, Colorectal cancer statistics, 2017, CA Cancer J Clin, 67, 177, 10.3322/caac.21395 Attal, 1996, A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome, N Engl J Med., 335, 91, 10.1056/NEJM199607113350204 Barlogie, 1997, Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma, Blood, 89, 789, 10.1182/blood.V89.3.789 Child, 2003, High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma, N Engl J Med, 348, 1875, 10.1056/NEJMoa022340 Attal, 2017, Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma, N Engl J Med, 376, 1311, 10.1056/NEJMoa1611750 D'Souza A, Fretham C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides, 2017. Available at: http://www.cibmtr.org. Accessed June 2018. Halm, 2002, Is volume related to outcome in health care? A systematic review and methodologic critique of the literature, Ann Intern Med, 137, 511, 10.7326/0003-4819-137-6-200209170-00012 Go, 2017, Association between treatment facility volume and mortality of patients with multiple myeloma, J Clin Oncol, 35, 598, 10.1200/JCO.2016.68.3805 Devereaux, 2002, Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis, JAMA, 288, 2449, 10.1001/jama.288.19.2449 Al-Hamadani, 2014, Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents, Am J Hematol, 89, 825, 10.1002/ajh.23753 Costa, 2015, Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma, Biol Blood Marrow Transplant, 21, 701, 10.1016/j.bbmt.2014.12.024 Fiala, 2015, Socioeconomic status is independently associated with overall survival in patients with multiple myeloma, Leuk Lymphoma, 56, 2643, 10.3109/10428194.2015.1011156 Winn, 2015, The real-world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma, J Natl Cancer Inst, 107, 10.1093/jnci/djv139 2001 Giri, 2015, Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study, Blood, 125, 3359, 10.1182/blood-2015-01-625764 Marmor, 2015, The impact of center accreditation on hematopoietic cell transplantation (HCT), Bone Marrow Transplant., 50, 87, 10.1038/bmt.2014.219 Mehta, 2016, Annual hospital volume of high dose interleukin-2 and inpatient mortality in melanoma and renal cell carcinoma patients, PloS One, 11, 10.1371/journal.pone.0147153 Sorror, 2013, How I assess comorbidities before hematopoietic cell transplantation, Blood, 121, 2854, 10.1182/blood-2012-09-455063